Skip to main content
Log in

“Two-route chemotherapy” using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, combined with angiotensin II is effective against peritoneally disseminated cancer in rats

  • Original Articles
  • Two-route Chemotherapy, Angiotensin II, Cis-Platinum (II), Chemotherapy
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

“Two-route chemotherapy” (TRC) using cis-diamminedichloroplatinum(II) (DDP) and its antidote, sodium thiosulfate (STS), combined with the angiotensin II (AT-II)-induced hypertension method was evaluated for its efficacy against peritoneally disseminated tumors in rats. A bolus i.p. injection of DDP (15 mg/kg) was given 1 min after the initiation of an AT-II (16.5 μg/kg) i.v. infusion lasting 11 min. Immediately after the termination of the AT-II infusion, 1,580 mg/kg STS was injected i.v. over a further 5 min. This modified TRC significantly improved the antitumor effect, evaluated by survival (increase in life span, 273%), compared with that achieved with other treatments, as follows: 15 mg/kg DDP i.p. and the concomitant i.v. infusion of 1,580 mg/kg STS (conventional TRC), 153% increase in life span; 5 mg/kg DDP i.p. with or without AT-II i.v. (167% and 107% increases in life span, respectively). As an index of nephrotoxicity, blood urea nitrogen (BUN) levels seen after modified TRC (21.1 mg/dl) were as low as those observed after conventional TRC (19.1 mg/dl), despite the postadministration of STS, and were much lower than those seen after DDP alone or DDP plus AT-II (35.6 and 35.7 mg/dl, respectively). Further evaluation of the effectiveness of modified TRC using various doses of DDP gave similar results. The feasibility of the administration of STS 10 min after DDP treatment was explained by the significant inhibition of DDP delivery to the kidney during the AT-II-induced hypertension. Thus, TRC combined with AT-II has a superior therapeutic effect against peritonitis carcinomatosa induced in rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aamdal S, Fodstad Ø, Pihl A (1988) Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum(II) in mice bearing murine and human tumors. Cancer Chemother Pharmacol 21: 129

    Google Scholar 

  2. Baba T, Nishikawa K (1980) Effective combination of anticancer drug with its antidote for chemotherapy of hepatic metastasis. Gann 71: 157

    Google Scholar 

  3. Bannister SJ, Chang Y, Sternson LA, Repta AJ (1978) Atomic absorption spectrophotometry of free circulating platinum species in plasma derived from cis-dichlorodiammineplatinum(II). Clin Chem 24: 877

    Google Scholar 

  4. Casper ES, Kelsen DP, Alcock NW, Lewis JL Jr (1983) I.p. cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the i.v. route. Cancer Treat Rep 67: 235

    Google Scholar 

  5. Chen KK, Rose CL (1952) Nitrite and thiosulfate therapy in cyanide poisoning. J Am Med Assoc 149: 113

    Google Scholar 

  6. Dedrick RL, Myers CE, Bungary PM, DeVita VT (1978) Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 62: 1

    Google Scholar 

  7. Fawcett JK, Scott JE (1960) A rapid and precise method for the determination of urea. J Clin Pathol 13: 156

    Google Scholar 

  8. Fukushima S, Hirose M, Tsuda H, Shirai T, Hirao K, Arai M, Ito N (1976) Histological classification of urinary bladder cancers in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Gann 67: 81

    Google Scholar 

  9. Hatae M, Tezuka H, Ushiki N, Ezono Y, Igyuin H, Terahara M, Hokanishi H (1984) Intraperitoneal and intrapleural two channel chemotherapy by cis-dichlorodiammineplatinum(II) (DDP)-sodium thiosulfate (STS) to ovarian cancer and peritonitis carcinomatosa. Jpn J Cancer Chemother 11: 433

    Google Scholar 

  10. Hori K, Suzuki M, Abe I, Saito S, Sato H (1985) Increase in tumor vascular area due to increased blood flow by angiotensin II in rats. J Natl Cancer Inst 74: 453

    Google Scholar 

  11. Howell SB, Taetle R (1980) Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia. Cancer Treat Rep 64: 611

    Google Scholar 

  12. Howell SB, Pfeifle CL, Wung WE, Olshen RA, Lucas WE, Yon JL, Green M (1982) Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 97: 845

    Google Scholar 

  13. Howell SB, Pfeifle CE, Wung WE, Olshen RA (1983) Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection. Cancer Res 43: 1426

    Google Scholar 

  14. Ishizawa M, Taniguchi S, Baba T (1981) Protection by sodium thiosulfate and thiourea against lethal toxicity of cis-diamminedichloroplatinum(II) in bacteria and mice. Jpn J Pharmacol 31: 883

    Google Scholar 

  15. Iwamoto Y (1985) “Two-route chemotherapy” using high-dose intra-arterial cis-diamminedichloroplatinum(II) and systemic sodium thiosulfate, its antidote, for rat limb tumor. J Jpn Orthop Assoc 59: 865

    Google Scholar 

  16. Iwamoto Y, Aoki K, Kawano T, Baba T (1984) Upper hemibody infusion of cis-diamminedichloroplatinum(II) followed by systemic antidote, sodium thiosulfate, for lung metastasis in rats. Clin Exp Metastasis 2: 261

    Google Scholar 

  17. Iwamoto Y, Kawano T, Uozumi J, Aoki K, Baba T (1984) “Two-route chemotherapy” using high-dose ip cisplatin and iv sodium thiosulfate, its antidote, for peritoneally disseminated cancer in mice. Cancer Treat Rep 68: 1367

    Google Scholar 

  18. Iwamoto Y, Kawano T, Ishizawa M, Aoki K, Kuroiwa T, Baba T (1985) Inactivation of cis-diamminedichloroplatinum(II) in blood and protection of its toxicity by sodium thiosulfate in rabbits. Cancer Chemother Pharmacol 15: 228

    Google Scholar 

  19. Koba F, Tsuji H, Abe R, Asoh T, Miyazaki S, Shirasaka C, Takeuchi Y, Arinaga S, Wada T, Uchida I, Akiyoshi T, Baba T (1983) Two-route infusion chemotherapy for primary and metastatic liver cancer. Jpn J Cancer Chemother 10: 1684

    Google Scholar 

  20. Konishi T, Kitamura M, Suzuki T, Mori T, Awane Y, Kosaki G (1985) Intra-arterial infusion therapy with angiotensin II for gastric carcinoma. Jpn J Cancer Chemother 12: 1905

    Google Scholar 

  21. Krakoff IH (1979) Nephrotoxicity of cis-dichlorodiammineplatinum(II). Cancer Treat Rep 63: 1523

    Google Scholar 

  22. Kuroiwa T, Aoki K, Taniguchi S, Hasuda K, Baba T (1987) Efficacy of two-route chemotherapy using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, in combination with angiotensin II in a rat limb tumor. Cancer Res 47: 3618

    Google Scholar 

  23. Litchfield JT Jr, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 95: 99

    Google Scholar 

  24. Markman M (1986) Intracavitary chemotherapy. Curr Probl Cancer 10: 402

    Google Scholar 

  25. Markman M, Cleary S, Pfeifle CE, Howell SB (1985) High-dose intracavitary cisplatin with intravenous thiosulfate. Cancer 56: 2364

    Google Scholar 

  26. Newman EV, Gilman A, Philips FS (1946) The renal clearance of thiosulfate in man. Bull Johns Hopkins Hosp 79: 229

    Google Scholar 

  27. Noda T, Oku M, Kiyozuka Y, Ninomiya Y, Hino K, Okamura Y, Maruyama M, Ichijo M (1987) Intraperitoneal high-dose cisplatin chemotherapy (CDDP-ip) in patients with carcinomatous peritonitis. Jpn J Cancer Chemother 14: 1025

    Google Scholar 

  28. Noguchi S, Miyauchi K, Nishizawa Y, Sasaki Y, Imaoka S, Iwanaga T, Koyama H, Terasawa T (1988) Augmentation of anticancer effect with angiotensin II in intraarterial infusion chemotherapy for breast carcinoma. Cancer 62: 467

    Google Scholar 

  29. Nojiri O, Nakamura M, Tanaka Y, Banno T (1988) Two-route chemotherapy by CDDP and STS against liver metastasis of gastrointestinal adenocarcinoma. Jpn J Cancer Chemother 15: 47

    Google Scholar 

  30. Ozols RF, Locker GY, Doroshow JH, Grotzinger KR, Myers CE, Young RC (1979) Pharmacokinetics of Adriamycin and tissue penetration in murine ovarian cancer. Cancer Res 39: 3209

    Google Scholar 

  31. Pretorius RG, Petrilli ES, Kean C, Ford LC, Hoeschele JD, Lagasse LD (1981) Comparison of the iv and ip routes of administration of cisplatin in dogs. Cancer Treat Rep 65: 1055

    Google Scholar 

  32. Riabchikov DI (1941) The reactions with thiosulfate as a method for determining the nature of isomerism of platinum complex compounds. C R (Dokl) Acad Sci URSS 32: 344

    Google Scholar 

  33. Rosivall L, Navar LG (1983) Effects of renal hemodynamics of intra-arterial infusions of angiotensins I and II. Am J Physiol 245 (Renal Fluid Electrolyte Physiol 14): F181

  34. Sagiyama K, Uozumi J, Aoki K, Baba T (1983) Efficacy of “two-route chemotherapy” using intra-arterial cisplatin and iv sodium thiosulfate, its antidote, in rat bladder tumor. Cancer Treat Rep 67: 567

    Google Scholar 

  35. Sato H, Hoshi M, Wakui A (1986) Clinical study on angiotensin-induced hypertension chemotherapy (IHC). Jpn J Cancer Chemother 13: 1439

    Google Scholar 

  36. Suzuki M, Hori K, Abe I, Saito S, Sato H (1981) A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with antiotensin II. J Natl Cancer Inst 67: 663

    Google Scholar 

  37. Takematsu H, Tomita Y, Kato T (1985) Angiotensin-induced hypertension and chemotherapy for multiple lesions of malignant melanoma. Br J Dermatol 113: 463

    Google Scholar 

  38. Taniguchi S, Baba T (1982) “Two-route chemotherapy” using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, for peritoneally disseminated cancer in rats. Gann 73: 475

    Google Scholar 

  39. Uozumi J, Sagiyama K, Aoki I, Iwamoto Y, Baba T (1983) Effectiveness of “two-route chemotherapy” using cisplatin and its antidote, sodium thiosulfate, on the lifespan of rats bearing metastatic liver tumors. Cancer Treat Rep 67: 1067

    Google Scholar 

  40. Uozumi J, Ishizawa M, Iwamoto Y, Baba T (1984) Sodium thiosulfate inhibits cis-diamminedichloroplatinum(II) activity. Cancer Chemother Pharmacol 13: 82

    Google Scholar 

  41. Von Hoff DD, Schilsky R, Reichert CM, Reddick RL, Rozencweig M, Young RC, Muggia FM (1979) Toxic effects of cis-dichlorodiammineplatinum(II) in man. Cancer Treat Rep 63: 1527

    Google Scholar 

  42. Wolpert-DeFilippes MK (1979) Antitumor activity of cis-dichlorodiammineplatinum(II). Cancer Treat Rep 63:1453

    Google Scholar 

  43. Yano T, Kobayashi H, Inoue H, Uchiyama N, Onohara S, Sonoda T, Shinohara S (1985) Two-channel bronchial artery infusion of cisplatin for treatment of primary lung cancer. Nippon Acta Radiol 45: 486

    Google Scholar 

  44. Young RC, Von Hoff DD, Gormley P, Makuch R, Cassidy J, Howser D, Bull JM (1979) cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer. Cancer Treat Rep 63: 1539

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Education, Science and Culture, Japan

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kobayashi, H., Hasuda, K., Aoki, K. et al. “Two-route chemotherapy” using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, combined with angiotensin II is effective against peritoneally disseminated cancer in rats. Cancer Chemother. Pharmacol. 24, 141–147 (1989). https://doi.org/10.1007/BF00300233

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00300233

Keywords

Navigation